Dear Readers,


Happy new year!


Flora Mok and myself were privileged to attend the Asian Financial Forum, the Asia Private Equity Forum and the 2018 Family Offices Solutions Showcase and Asia Co-Investors workshops recently in Hong Kong.  The Asian Financial Forum is an annual gathering of foremost financial and business leaders.     

We were also able to meet a number of our investors and counterparties as well as meet new funds and family offices looking to deploy capital.

Our first newsletter for 2018 includes:

I also invite you to download our current deal list from our website (log-in required, membership is free).  For more information please contact us.  

We hope your start to the new year was as good as ours and we look forward to working with our investors, issuers and associates during the coming year.   


Mark Rainbird 

Managing Director 

Funding Strategies

About

 Funding Strategies


Funding Strategies is a capital markets firm providing strategic advice, venture equity capital and finance services to small business and companies seeking capital for growth and expansion in the unlisted, pre-IPO and listed capital markets. We specialise in creating and implementing successful funding and capital raising strategies. 


We serve predominately private and public companies, and sophisticated investors, with a broad range of services: 

  • Corporate Advisory
  • Funding Strategies and Investor Ready Services
  • Equity and Debt Capital Raisings
  • Small Scale Offerings and Venture Capital
  • Grant Funding
  • Special Private Placements
  • Stock Exchange Listings
  • Mergers, Acquisitions and Divestments
  • Strategic Trade Sales
  • Technology Commercialization
  • Real Estate Debt and Equity Financing and Restructuring
  • Providing Opportunities for Investors
  • Director and business advisory services
  • Migration Investment SIV 132A, 132B and 188E
  • Fund Management / Venture Funds

   
   
   
   

 Introducing Support Management Solutions


Support Management Solutions Pty Ltd is an Australian company in the advanced stages of configuring custom digital solutions for Customer Directed Care initiatives in the disability sector under the National Disability Insurance Scheme.

The First2Care solution is the software platform developed by SMS for the Disability Sector's Customer Directed Care government initiative. First2Care puts the participant (person receiving funding) at the centre of the relationship. The functionality of the First2Care solution is designed to solve problems associated with the significant disruption to establish markets arising from introduction of the NDIS.


"First2Care is an easy-to-use mobile app for NDIS participants, planners, support workers and service providers. Take control of your NDIS funding  and connect, plan,coordinate

 and manage your NDIS support your way." 

   

 Introducing Engender Technologies


Engender is a New Zealand company that has developed a proprietary process to separate bull sperm cells by sex, enabling cattle farmers to choose the gender of offspring. 

Engender uses photonics and microfluidic chips to sort sperm. Its process is expected to be low cost, have minimal impact on fertility and achieve increased sperm count retention compared to the only existing technology. Gender sorting will accelerate genetic gain and improve cost efficiencies in large animal reproduction. The company’s initial target market is the dairy industry, but it expects its technology can be applied to other markets. 


Engender has confirmed its technology’s ability to achieve enrichment of X-chromosome bearing (female producing) sperm cells. The Company recently learned that its key patent was allowed in the US and Australia. 

   

 Introducing Project Karkinos


"A Revolutionary New Concept for Treating Cancer"


Project Karkinos is a US biopharma company that has developed a family of nanomedicine drugs, which destroy blood vessels in solid tumours (up to 85% of all cancers). 

Project Karkinos’ lead drug is a gold bound tumour necrosis factor which breaks apart blood vessels and enables chemotherapeutics to penetrate and kill cancer cells  The lead drug has successfully completed human Phase 1 Safety studies.   


The lead drug’s action of perforating tumour blood vessels and reducing tumour pressure may make existing cancer therapies safer and more effective, by allowing for the increased concentration of cancer drugs into a tumour.


"Project Karkinos has the potential to improve clinical outcomes

 in many solid tumour cancers"


For more information about Project Karkinos, please contact us

   

 Dealer Trade Limited


Progress Report

Dealer Trade has provided an update in regards to:

  • Gumtree - CarRecord Partnership
  • New Manufacturer - Suzuki QLD
  • Dealer Trade UK
  • Fairfax - CarRecord Discussion
Additionally, Suzuki QLD confirmed "that they have achieved a 100% clearance of their units from their inaugural auction event".

As of January 2018, Dealer Trade has increased their global dealership list to almost 3,500, including "the dealers currently signed up by the UK operation thus far. They will be open for business by early February."  

   
   
 Squirrel Limited 

Squirrel acquires London based 
FCA licensed financial service

"Squirrel Limited through its wholly owned UK based subsidiary, Squirrel Money Limited, is pleased to announce it has acquired a London based FCA licensed financial service. This acquisition will expedite Squirrel’s entry into the one of the world’s fastest growing markets for self-directed pensions at turning point for UK financial services resulting from the implementation of Open Banking on 13 January 2018."

Congratulations 

Damien & team!

   

 AqMB Pty Ltd


"PFD export to CAD software, smartPFD mode, plant rollback & simplified stream numbering"

"AqMB™ is the most affordable water treatment software platform for concept design, process modelling and predictive analytics. Developed by engineers for designers, consultants and operators."

   
   
BlueMount Capital 

BlueMount Capital wins IPO award

Congratulations to the team at BlueMount Capital, who have been named as Australian IPO awards winner 2018 by the International Advisory Experts group. 
Upcoming ACBC QLD event 

We hope you will join Flora and me at Australia China Business Council's upcoming event on 28 February in Brisbane:



Annual Chinese New Year Dinner 2018

 Celebrating the Year of the Dog 


"The Annual Chinese New Year Dinner is the signature event in the Australia China Business Council's calendar. Celebrate the Year of the Dog in style with ACBC business networks and government and community leaders". 

   
   
   

Your Funding Strategies team

Back row (left to right): Ken Freer, Adam Atkins, Gary Bartlam, Mark Rainbird, Stephen Varty

Front row (left to right): Eugenia Arrarte, Flora Mok, Andrew Michell, Birgit Rainbird

   
Funding Strategies Pty Ltd
ACN 161 432 123
Level 5, 15 Astor Terrace, Spring Hill QLD 4000
Telephone +61 7 3160 2840

Facebook    |     LinkedIn

                Tell-A-Friend

You are receiving this email because you are a valued contact and have provided us with your details in the past. If you ever wish to change your personal details simply update your profile, or to unsubscribe, click the unsubscribe link located at the bottom of any of our emails.

This email is not an offer to invest in securities and is made in accordance with section 708 of the Corporations Act.

If you have received this email in error, please email with the Subject line of "Unsubscribe" or alternatively click the unsubscribe link located at the bottom of any of our emails. .
 
Not interested? Unsubscribe | Update profile | Impressed? Tell-A-Friend
Funding Strategies Pty Ltd | Level 5 | 15 Astor Terrace | Spring Hill QLD 4000 | Australia